Zemaira is used for chronic augmentation and maintenance therapy for adults with Alpha-1 deficiency and emphysema. Zemaira may not be appropriate for the following adult individuals as they may experience severe reactions, including anaphylaxis: individuals with a known hypersensitivity and/or history of anaphylaxis or severe systemic reaction to A1-PI products or their components, and individuals with selective IgA deficiencies who have known antibodies against IgA.
Alpha 1 Deficiency Treatment
Alpha 1 Deficiency Treatment - Zemaira
2024-06-12
Zemaira is used for chronic augmentation and maintenance therapy for adults with Alpha-1 deficiency and emphysema. Zemaira may not be appropriate for the following adult individuals as they may experience severe reactions, including anaphylaxis: individuals with a known hypersensitivity and/or history of anaphylaxis or severe systemic reaction to A1-PI products or their components, and individuals with selective IgA deficiencies who have known antibodies against IgA.